Novel Risk Factors Related to Stable Angina

E-ISSN： 1873-4286|19|9|1550-1561

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1550-1561

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topics: Stable Angina Pectoris: Novel Therapeutic Insights)

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-01 ,pp. : 1549-1549

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1581-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Trimetazidine for stable angina pectoris

By Cross H.R.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 857-875

Informa Healthcare

Access to resources Recommend Favorite

Effect of Antianginal Drugs in Stable Angina on Predicted Mortality Risk after Surviving a Myocardial Infarction: A Preliminary Study (METRO)

By Iyengar Shamanna S.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 293-297

Adis International

Access to resources Recommend Favorite

Nicorandil: A Review of its Use in the Management of Stable Angina Pectoris, Including High-Risk Patients

By Simpson Dene Wellington Keri

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1941-1955

Adis International

Access to resources Recommend Favorite